Document is current
Any future updates will be listed below
-
Authors
,
Alviggi, Carlo http://orcid.org/0000-0001-9116-020X
Esteves, Sandro C. http://orcid.org/0000-0002-1313-9680
Orvieto, Raoul
Conforti, Alessandro
La Marca, Antonio
Fischer, Robert
Andersen, Claus Y.
Bühler, Klaus
Sunkara, Sesh K.
Polyzos, Nikolaos P.
Strina, Ida
Carbone, Luigi
Bento, Fabiola C.
Galliano, Daniela
Yarali, Hakan
Vuong, Lan N.
Grynberg, Michael
Drakopoulos, Panagiotis
Xavier, Pedro
Llacer, Joaquin
Neuspiller, Fernando
Horton, Marcos
Roque, Matheus
Papanikolaou, Evangelos
Banker, Manish
Dahan, Michael H.
Foong, Shu
Tournaye, Herman
Blockeel, Christophe
Vaiarelli, Alberto
Humaidan, Peter
Ubaldi, Filippo M.
- License Information
-
More Information
Article History
Received: 15 April 2020
Accepted: 28 April 2020
First Online: 13 May 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable.
: CA and SE declare the receipt of unrestricted research grants from Merck, and lecture fees from Merck. RO, AC, RF, FN, and MR have received honoraria for lectures from Merck. ALM has received unrestricted research grants from MSD, Merck, Ferring, Theramex, Beckman Coulter, IBSA, Gedon-Richter, Roche as well as honoraria for lectures from the same companies. KB has received honoraria for lectures from Bayer and Merck, and unrestricted research grant from Theramex. SS declares the receipt of honorarium for lectures from Merck, MSD, and Ferring. NP has received unrestricted grants or lecture fees from Merck, MSD, Gedeon-Richter, IBSA, Besins, Ferring Pharmaceuticals, and Theramex. HY and MH declares receipt of honorarium for lectures from Merck and Ferring. LV has received speaker’s fees from Merck, Ferring, and research grants from MSD. PD declare the receipt of honorarium for lectures from Merck, MSD, and Ferring, and unrestricted research grant form MSD. PX declares receipt of lecture fees from Merck, Gedeon-Richter, Ferring, and MSD. JL has received research grants from MSD and IBSA, Merck as well as honoraria for lectures from MSD, Merck, Ferring, Theramex, and IBSA. CB has received unrestricted grants and lecture fees from Abbott, MSD, Gedeon-Richter, and Ferring Pharmaceuticals. HT has received grants from Roche, MSD, Cook, Ferring, Research Funders of Flanders, Gedeon-Richter, Abbott, and ObsEva, as well as consulting fees from Gedeon-Richter, Abbott, and ObsEva. PH has received unrestricted research grants from MSD and Merck, as well as honoraria for lectures from MSD, Merck, Gedeon–Richter, Theramex, and IBSA. The remaining authors (CYA, FCB, ID, LC, DG, MG, MB, MHD, HT, EP, SF, AV, and FMU) declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
